Table 2.
The results of a meta-analysis of 14 papers, in which differences in gene expression profile between follicular thyroid cancers (FTC) and follicular thyroid adenomas (FTA) were assessed by a high throughput method. Ten genes (highlighted in bold) were selected for our qRT-PCR validation.
No. | Entrez Gene ID | Symbol | Name | Number of Papers | References | Gene Regulation |
---|---|---|---|---|---|---|
1 | 762 | CA4 | carbonic anhydrase IV | 3 | [5,9,16] | down |
2 | 1959 | EGR2 | early growth response 2 | 3 | [5,14,16] | down |
3 | 9413 | FAM189A2 | family with sequence similarity 189, member A2 | 3 | [5,9,12] | down |
4 | 7881 | KCNAB1 | potassium voltage-gated channel, shaker-related subfamily, beta member 1 | 3 | [6,9,16] Confirmed by us [27] |
down |
5 | 10404 | CPQ | carboxypeptidase Q | 3 | [9,11,14] | down |
6 | 5172 | SLC26A4 | solute carrier family 26 (anion exchanger), member 4 | 3 | [6,14,16] | down |
7 | 7033 | TFF3 | trefoil factor 3 (intestinal) | 3 | [5,6,10] | down |
8 | 185 | AGTR1 | angiotensin II receptor, type 1 | 2 | [13,16] | down |
9 | 822 | CAPG | capping protein (actin filament), gelsolin-like | 2 | [14,17] | down |
10 | 1306 | COL15A1 | collagen, type XV, alpha 1 | 2 | [5,13] | down |
11 | 1363 | CPE | carboxypeptidase E | 2 | [9,17] | down |
12 | 3491 | CYR61 | cysteine-rich, angiogenic inducer, 61 | 2 | [8,16] | down |
13 | 1733 | DIO1 | deiodinase, iodothyronine, type I | 2 | [6,12] | down |
14 | 11072 | DUSP14 | dual specificity phosphatase 14 | 2 | [5,16] | down |
15 | 129080 | EMID1 | EMI domain containing 1 | 2 | [5,7] | down |
16 | 953 | ENTPD1 | ectonucleoside triphosphate diphosphohydrolase 1 | 2 | [9,14] | down |
17 | 8857 | FCGBP | Fc fragment of IgG binding protein | 2 | [5,17] | down |
18 | 2354 | FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 2 | [16,17] | down |
19 | 2697 | GJA1 | gap junction protein, alpha 1, 43 kDa | 2 | [5,11] | down |
20 | 55830 | GLT8D1 | glycosyltransferase 8 domain containing 1 | 2 | [5,11] | down |
21 | 221395 | GPR116 | G protein-coupled receptor 116 | 2 | [5,9] | down |
22 | 3043 | HBB | hemoglobin, beta | 2 | [12,15] | down |
23 | 3309 | HSPA5 | heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa) | 2 | [9,17] | down |
24 | 3400 | ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 2 | [5,8] | down |
25 | 3590 | IL11RA | interleukin 11 receptor, alpha | 2 | [5,11] | down |
26 | 9452 | ITM2A | integral membrane protein 2A | 2 | [9,16] | down |
27 | 3708 | ITPR1 | inositol 1,4,5-trisphosphate receptor, type 1 | 2 | [5,11] | down |
28 | 3725 | JUN | jun proto-oncogene | 2 | [5,16] | down |
29 | 3912 | LAMB1 | laminin, beta 1 | 2 | [5,11] | down |
30 | 744 | MPPED2 | metallophosphoesterase domain containing 2 | 2 | [16,17] | down |
31 | 22795 | NID2 | nidogen 2 (osteonidogen) | 2 | [5,7] | down |
32 | 3164 | NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 2 | [12,16] | down |
33 | 22925 | PLA2R1 | phospholipase A2 receptor 1, 180 kDa | 2 | [12,16] | down |
34 | 83483 | PLVAP | plasmalemma vesicle associated protein | 2 | [9,13] | down |
35 | 5583 | PRKCH | protein kinase C, eta | 2 | [9,14] | down |
36 | 23180 | RFTN1 | raftlin, lipid raft linker 1 | 2 | [5,9] | down |
37 | 8490 | RGS5 | regulator of G-protein signaling 5 | 2 | [9,13] | down |
38 | 6414 | SEPP1 | selenoprotein P, plasma, 1 | 2 | [5,14] | down |
39 | 7038 | TG | Thyroglobulin | 2 | [10,17] | down |
40 | 4982 | TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b | 2 | [5,11] | down |
41 | 7173 | TPO | thyroid peroxidase | 2 | [10,17] | down |
42 | 440 | ASNS | asparagine synthetase (glutamine-hydrolyzing) | 2 | [5,9] | up |
43 | 771 | CA12 | carbonic anhydrase XII | 2 | [5,12] | up |
44 | 1164 | CKS2 | CDC28 protein kinase regulatory subunit 2 | 2 | [16,17] | up |
45 | 1649 | DDIT3 | DNA-damage-inducible transcript 3 | 2 | [5,7] | up |
46 | 2358 | FPR2 | formyl peptide receptor 2 | 2 | [5,11] | up |
47 | 9518 | GDF15 | growth differentiation factor 15 | 2 | [9,17] | up |
48 | 2896 | GRN | Granulin | 2 | [4,8] | up |
49 | 3486 | IGFBP3 | insulin-like growth factor binding protein 3 | 2 | [5,10] | up |
50 | 23089 | PEG10 | paternally expressed 10 | 2 | [5,11] | up |
Table 2 shows the Entrez ID, gene symbol, gene name, number of papers in which a particular gene occurs, references to the papers, regulation direction (up–up-regulated in FTC; down–down-regulated in FTC).